2 Jun 2025 Based in Hong Kong, SinoMab is a pioneering biopharmaceutical company specializing in the research, development, manufacturing, and commercialization of therapeutics for immunological diseases, with a primary focus on monoclonal antibody (mAb)-based biologics. Since its inception, SinoMab has
30 May 2025 Kuaishou’s 1QFY25 revenue was up by 10.9% YoY to Rmb32.6bn, mainly due to i) 8% YoY increase in online marketing services to Rmb18.0bn, driven by higher spending from marketing clients; ii) 14% YoY increase in live streaming
29 May 2025 During the period under review, Johnson Electric (JE) faced mounting challenges across its key downstream markets. These difficulties stemmed from a decline in automobile production, heightened price competition in several consumer and industrial segments, and weakened consumer
23 May 2025 SunArt’s FY25 (Mar-end) revenue was down by 1.4% YoY to Rmb71.6bn, mainly due to i) the contraction of supply chain business and store closures which accounted for 1.4% decline in sales; and ii) closures on loss making
20 May 2025 Man Wah reported its Mar ended FY25 results with top line declined by 8.2% YoY to HK$17.2bn. GPM increased by 1.1ppt YoY to 40.5%. The improvement in overall GPM was mainly attributed to the declining RM prices,
09 May 2025 Haier announced its 1QFY25 quarterly results, with operating revenue increased by 10.1% YoY to Rmb79.12bn GPM for the quarter was up by 0.1ppt YoY to 25.4%, with the increase driven by further digitalization from manufacturing to sales,
2 May 2025 Wasion announced that both Indonesian and Malaysian facilities have commenced operation in April 2025.
29 Apr 2025 Xtep announced its 1Q25 operational results, with retail sales for its Xtep Core Brand recorded a MSD growth YoY, slowing down from HSD/HSD growth in 4Q24/1Q24. While offline sales recorded LSD YoY growth amid less foot traffic,
28 April 2025
25 April 2025 Precision Tsugami (China) (PTC) issued a positive profit alert citing that the company expects its FY25 (Yr-ended Mar) net profit to increase by approximately 60% YoY to Rmb782m compared to FY24 net profit of Rmb480m. This encouraging
